FAM159B was also expressed in many of the 28 tumour entities investigated, with high levels in medullary and anaplastic thyroid carcinomas, parathyroid adenomas, lung and ovarian carcinomas, lymphomas and neuroendocrine tumours of different origins. This evidence concerns the gene SHISAL2B and thyroid gland undifferentiated (anaplastic) carcinoma.